Type I interferons (IFN-I) are critical for antiviral immunity; however, chronic IFN-I signaling is associated with hyperimmune activation and disease progression in persistent infections. We demonstrated in mice that blockade of IFN-I signaling diminished chronic immune activation and immune suppression, restored lymphoid tissue architecture, and increased immune parameters associated with control of virus replication, ultimately facilitating clearance of the persistent infection. The accelerated control of persistent infection induced by blocking IFN-I signaling required CD4 T cells and was associated with enhanced IFN-γ production. Thus, we demonstrated that interfering with chronic IFN-I signaling during persistent infection redirects the immune environment to enable control of infection.
CD4 + and CD8 + T cell functions are rapidly aborted during chronic infection, preventing viral clearance. CD4 + T cell help is required throughout chronic infection so as to sustain CD8 + T cell responses; however, the necessary factor(s) provided by CD4 + T cells are currently unknown. Using a mouse model of chronic viral infection, we demonstrated that interleukin-21 (IL-21) is an essential component of CD4 + T cell help. In the absence of IL-21 signaling, despite elevated CD4 + T cell responses, CD8 + T cell responses are severely impaired. CD8 + T cells directly require IL-21 to avoid deletion, maintain immunity, and resolve persistent infection. Thus, IL-21 specifically sustains CD8 + T cell effector activity and provides a mechanism of CD4 + T cell help during chronic viral infection.During chronic viral infections, antiviral CD4 + and CD8 + T cells become non-responsive to viral antigens and are either physically deleted or persist in a nonfunctional "exhausted" state, unable to produce important antiviral and immunostimulatory cytokines such as interleukin-2 (IL-2), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ); lyse virally infected cells; or proliferate (1-4). To date, the majority of work analyzing T cell exhaustion during chronic viral infection has focused on CD8 + T cells; however, CD4 + T cells also exhibit reduced function, thus further exacerbating viral persistence. CD4 + T cells are required throughout chronic viral infection in order to sustain CD8 + T cell function and control infection, prevent deletion of high-affinity antiviral CD8 + T cells, and eventually resolve the infection (5-7). The loss of CD4 + and CD8 + T cell function is associated with viruses that establish chronic viral infections in their hosts: HIV and hepatitis B and hepatitis C virus (HCV) in humans and lymphocytic chorio-meningitis virus (LCMV) in rodents (8)(9)(10)(11)(12). Chronic LCMV infection is eventually controlled in the periphery 60 to 80 days after infection in a CD4 + T cell-dependent manner, suggesting that exhausted CD4 + T cells retain helper activity. Expression of the key CD4 + T cell helper cytokine IL-2, however, is rapidly extinguished during viral persistence (4,13), indicating that an alternative helper mechanism is being implemented.To determine how CD4 + T cells help CD8 + T cells to clear a viral infection, we infected mice with the Armstrong strain of LCMV (Arm) that induces a robust T cell response, resulting in viral clearance within 8 to 10 days or with the Clone 13 strain of LCMV (Cl 13) that generates a chronic infection due to the up-regulation of immunosuppressive factors that induce a dramatic depletion and inactivation of virus-specific T cells (14-18). LCMV-Arm and -Cl 13 share identical CD4 + and CD8 + T cell epitopes, enabling direct comparison of
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.